Empire Financial Management Company, LLC Bristol Myers Squibb CO Transaction History

Empire Financial Management Company, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $244,026 - $276,678	-5,086 Reduced 29.87%	11,940 $648 Million
Q4 2023 Feb 15, 2024	SELL	$48.48 - $57.85 $621,465 - $741,579	-12,819 Reduced 42.95%	17,026 $874 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $26,629 - $29,775	-460 Reduced 1.52%	29,845 $1.73 Billion
Q2 2023 Jul 27, 2023	BUY	$63.71 - $70.74 $1.61 Million - $1.79 Million	25,265 Added 501.29%	30,305 $1.94 Billion
Q1 2023 Apr 20, 2023	BUY	$65.71 - $74.53 $331,178 - $375,631	5,040 New	5,040 $349 Million

2,535

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Empire Financial Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Empire Financial Management Company, LLC with notifications on news.